Erica F. Crannage

ORCID: 0000-0001-8509-9609
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Diabetes Treatment and Management
  • Innovations in Medical Education
  • Mentoring and Academic Development
  • Pharmaceutical Practices and Patient Outcomes
  • Chronic Disease Management Strategies
  • Diabetes Management and Education
  • Pharmacology and Obesity Treatment
  • Medical Education and Admissions
  • Health Literacy and Information Accessibility
  • Health and Medical Research Impacts
  • Atrial Fibrillation Management and Outcomes
  • Blood Pressure and Hypertension Studies
  • Perfectionism, Procrastination, Anxiety Studies
  • Prenatal Substance Exposure Effects
  • Renal Transplantation Outcomes and Treatments
  • Metabolism, Diabetes, and Cancer
  • Pharmaceutical studies and practices
  • Venous Thromboembolism Diagnosis and Management
  • Maternal Mental Health During Pregnancy and Postpartum
  • Digital Mental Health Interventions
  • Asthma and respiratory diseases
  • Potassium and Related Disorders
  • Gestational Diabetes Research and Management
  • Inhalation and Respiratory Drug Delivery
  • Pharmacological Effects and Assays

University of Health Sciences and Pharmacy
2015-2024

Mercy Clinic Neurology
2021

American College of Clinical Pharmacy
2020

Saint Louis University
2016

Saint Louis University
2015-2016

Saint Louis College La Union
2016

UCLouvain Saint-Louis Brussels
2016

We utilized a 4D framework using ease of implementation, novelty, necessity, and fit the overall industry to examine adoption blockchain technology in pharmaceutical industry. Based on 2D difficulty novelty as driving factors for development foundational technologies world business by Iansiti Lakhani, each application was ranked scored best potential implementation. The applications proposed this paper can be grouped into two main categories. first category, management, includes best-use...

10.30953/bhty.v7.298 article EN cc-by-nc Blockchain in Healthcare Today 2024-04-18

The purpose of the study was to determine whether there are any race-related disparities in prevalence provisions for diabetes education primary care clinics patients with and prediabetes.A retrospective cross-sectional 3967 aged 14 >89 years prediabetes diabetes. Medical record data from patient encounters within at a large academic medical health system between July 1, 2008, 31, 2013, were used rates referral by race. Multivariate logistic regression models assess associations race...

10.1177/0145721715574604 article EN The Diabetes Educator 2015-02-27

Abstract Problem Smartphone applications are an increasingly useful part of patients' self‐management chronic health conditions. Asthma is a common condition for which good by patients very helpful in maintaining stability. User‐centered design and intelligent systems that learn steps forward building more effective providing quality care scalable tailored to each patient. Methods A literature application store search review historic current asthma smart phone applications. methodology...

10.1002/lrh2.10217 article EN cc-by Learning Health Systems 2020-02-18

<h3>Background:</h3> The medical home model has been gaining attention from the health care community as a strategy for improved outcomes management of chronic disease, including diabetes. purpose this study was to compare referrals diabetes education among patients receiving versus traditional practice. <h3>Methods:</h3> Data were obtained large, university-affiliated primary patient data registry. All (age 18–96 years) with diagnosis prediabetes or and seen by physician at least twice...

10.3122/jabfm.2016.03.150370 article EN The Journal of the American Board of Family Medicine 2016-05-01

Abstract Mentorship is vital for pharmacy trainees to develop professional skills and networks. This paper aims share the development implementation of a national remote mentorship program within American College Clinical Pharmacy Ambulatory Care Practice Research Network. We offer recommendations developing similar organizations emphasizing program's framework as resource initiatives. The following key are proposed enhance programs: (1) Program flexibility tailored interactions; (2)...

10.1002/jac5.1919 article EN cc-by-nc JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 2024-01-11

To highlight the prevalence and impact of obesity in United States provide nurse practitioners (NPs) with an overview pharmacotherapy options for treatment overweight obese individuals.A comprehensive review literature was conducted using multiple databases, including PubMed, MEDLINE, Ovid. Keywords used to obtain relevant articles included drug, or orlistat, topiramate/phentermine, lorcaserin, bupropion/naltrexone, liraglutide.Obesity is a prevalent disease more than two thirds Americans...

10.1002/2327-6924.12279 article EN Journal of the American Association of Nurse Practitioners 2015-06-26

Abstract Faculty development is a priority for colleges and schools of pharmacy both corporate individual success. Recommendations in the 2008 American College Clinical Pharmacy (ACCP) position statement white paper on faculty remain relevant today. However, changes educational standards, delivery education, learners have prompted an update documents. This 2020 focuses three components: preceptor development, updates practice program formation implementation. The provides evidence...

10.1002/jac5.1233 article EN JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 2020-03-31

Background: While commonly prescribed today, direct oral anticoagulants (DOACs) have historically been avoided in patients with class III obesity or a weight >120 kg due to limited literature regarding the efficacy and safety this population. Objective: The overall objective was examine effectiveness of DOACs compared warfarin population obesity. Methods: Patients diagnosis venous thromboembolism (VTE) atrial fibrillation body mass index (BMI) ≥35 kg/m2 from August 1, 2015, 2020, were...

10.1177/87551225211064113 article EN Journal of Pharmacy Technology 2021-12-22

Objective: To summarize literature assessing the safety and efficacy of budesonide/formoterol, a low dose inhaled corticosteroid (ICS) long-acting beta agonist (LABA) used as needed for treatment adult patients with mild persistent asthma requiring step 2 therapy compared to plus short-acting (SABA) SABA monotherapy. Data Sources: A search PubMed (1966-October 2020), EMBASE (1973-October 2020) clinicaltrials.gov was conducted using following terms: budesonide, formoterol, needed, asthma....

10.52106/2766-3213.1025 article EN Medical and Clinical Research Open Access 2021-04-29
Coming Soon ...